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Should radiocontrast be diluted for operative cholangiography?The role of operative cholangiography for detecting common
bile duct stones and for delineating biliary anatomy is well estab-
lished. The ﬁrst operative cholangiogram was described by Mirizzi
in 1937 and popularized in the United States by Hickens.1,2 Opera-
tive cholangiography has resulted in improved detection of
common bile duct stones from 83% based on clinical ﬁndings alone
to over 95%.3 The introduction of portable C-arm ﬂuoroscopy in the
1970s by Berci and Steckell has even further improved the accuracy
of operative cholangiography.4
Controversy over the optimal concentration of iodinated radio-
contrast for operative cholangiography continues to exist. In the
original description of operative cholangiography, Mirizzi reported
using diluted 40% lipiodol (lipoiodine). Lipiodol (iodinated poppy
seed oil) has a high organic iodine content of 42% (420 mg/ml)
requiring dilution. In a similar early description of cholangiography,
a diluted 17.5% solution of iodopyracet (Diodrast) was used. The
authors noted that this diluted contrast ‘‘did not cast too dense
a shadow on the X-ray ﬁlm to obscure stones.’’ Diodrast, which is
rarely used today for cholangiography, has a very high 63.5% iodine
content (635 mg/ml), necessitating dilution. This is in comparison
to the more widely commercially available Conray (iothalamate
meglumine) and Hypaque (diatrazoate sodium) both of which
have an iodine content of 282 mg/ml (28.2%). Most commercially
available iodinated contrast media used today (both ionic and
nonionic) have organic iodine content ranging from 282 to
400 mg/ml.
There is scant literature on the optimal concentration to use for
operative cholangiography. One study involving over 1600 cholan-
giograms showed high accuracy using full strength Hypaque 60Fig. 1. Images of full strength cholangiography: A. pre-injection, B. 1 s, C. 2 s, 6 s
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doi:10.1016/j.ijsu.2009.06.010(iodine concentration 282 mg/ml).5 To date, there is no study
comparing diluted to full strength radiocontrast in a controlled
simulation of operative cholangiography.
It is worth noting that the package inserts of Conray and Hypa-
que do not provide clear instructions onwhich concentration to use
for direct cholangiography. Conray’s instructions for direct cholan-
giography reads, ‘‘The usual dose is 10 mL but as much as 25 mL
may be needed depending upon the caliber of the ducts. If desired,
the contrast agent may be diluted 1:1 with sodium chloride.’’ The
package insert of Hypaque 60 reads, ‘‘10–15 mL (sometimes up to
25 mL) of a 30–60 percent solution is injected or instilled into the
cystic duct or common bile duct, as indicated.’’
To control for the variability of biliary stones and body habitus
in the clinical setting, this study was performed using a cholangiog-
raphy simulator. To simulate operative cholangiography, an 80 cm
long segment of 5 mm diameter polyethylene intravenous tubing
was ﬁtted with an irregularly shaped completely radiolucent
4 mm nonoccluding bead (to simulate a common bile duct stone)
placed 8 cm from the distal tip of the tubing. To simulate a narrow
Sphincter of Oddi, the distal catheter tip was crimped. To simulate
the diffusing effect of an adult torso, a 2 l bag of saline was used as
a diffuser and placed under the tubing. Using high resolution
digital ﬂuoroscopy (GE Medical OEC 9600) C-arm, 10 ﬂuoroscopic
image runs over 6 s were obtained as 20 ml of either full strength
Conray (28.2% or 282 mg/ml organic iodine) or half strength
Conray diluted 1:1 with 0.9% normal saline (14.1% or 141 mg/ml
organic iodine) was slowly injected. Ability to visual the stone on
mock cholangiography was determined by the author, a board
certiﬁed general surgeon.. Images of half strength cholangiography: A. pre-injection, B. 1 s, C. 2 s, 6 s.
d. All rights reserved.
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cholangiography using full strength (282 mg/ml) and half strength
(141 mg/ml) of Conray are shown (Fig. 1).
Results: In each of the 10 runs, the bead visualized earlier with
full strength Conray and remained easy visible in both groups.
There was no over-opaciﬁcation with full strength Conray. There
was no difference in visualization of the simulated gallstone with
full strength versus half strength Conray.
Full strengthandhalf strengthConrayareequivalent in identifying
nonobstructingbiliarystonesduringsimulatedoperative cholangiog-
raphy. Older and rarely used iodinated contrast media (e.g. lipiodol
and iodopyracet) have a higher iodine concentration and when
used in the past required dilution to prevent over-opaciﬁcation. Con-
ray, however, is already adequately dilute for direct cholagiography.Conﬂicts of interest
None.
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